Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR). Issue 2 (December 2015) - Le, Dung; Crocenzi, Todd; Urum, Jennifer; Lutz, Eric; Laheru, Daniel; Sugar, Elizabeth; Vonderheide, Robert; Fisher, George; Ko, Andrew; Murphy, Aimee; McDougall, Katherine; Ferber, Sandy; et al.